LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin-target against Tasmanian Devil Facial Tumor Disease
Published: 8 February 2021| Version 1 | DOI: 10.17632/r93jptbhr2.1
Contributor:
Manuel Alejandro Fernandez-RojoDescription
This is raw experimental data (western-blots) available for the publication "LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin-target against Tasmanian Devil Facial Tumor Disease."
Files
Steps to reproduce
See STAR PROTOCOLS at the publication "LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin-target against Tasmanian Devil Facial Tumor Disease."
Institutions
Instituto Madrileno de Estudios Avanzados
Categories
Cell Biology